Brief: Chordate Medical Holding Q4 Pre-Tax Loss Widens To SEK 8.1 Mln
Feb 28 (Reuters) - Chordate Medical Holding publ AB CMHM.ST :
* Q4 NET TURNOVER WAS SEK 20,347 (403,257)
* Q4 PROFIT/LOSS AFTER FINANCIAL ITEMS WAS SEK -8,078,967 (-7,191,338)
* FOCUS 2023: SALES AND MARKETING ON SELECT MARKETS FOR PROOF OF CONCEPT
* FOCUS 2023: PROJECTS FOR MARKETING AUTHORIZATION IN USA AND CHINA
* FOCUS 2023: STUDIES PM009 AND PM010
Source text for Eikon: ID:nMFN6xYStr
Further company coverage: CMHM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Chordate Medical Holding AB (publ)
See all newsBrief: Chordate Applies For Delisting
Brief: Chordate Medical Holding Says Last Day Of Trading Is In March 2026
Brief: Chordate Medical To Enter Into Voluntary Liquidation
Brief: Chordate Board Proposes AGM To Resolve On Voluntary Liquidation And Delisting
Brief: Chordate Medical Holding Q2 Net Loss SEK 5.2 Mln